US4675187A
(en)
|
1983-05-16 |
1987-06-23 |
Bristol-Myers Company |
BBM-1675, a new antibiotic complex
|
US4554162A
(en)
|
1984-05-04 |
1985-11-19 |
Warner-Lambert Company |
CL-1724 Antibiotic compounds, their production and use
|
US4539203A
(en)
|
1984-11-13 |
1985-09-03 |
Warner-Lambert Company |
CL-1577D And CL-1577E antibiotic/antitumor compounds, their production and use
|
US4970198A
(en)
|
1985-10-17 |
1990-11-13 |
American Cyanamid Company |
Antitumor antibiotics (LL-E33288 complex)
|
US6018030A
(en)
|
1986-11-04 |
2000-01-25 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
US5079233A
(en)
|
1987-01-30 |
1992-01-07 |
American Cyanamid Company |
N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
|
US5037651A
(en)
|
1987-01-30 |
1991-08-06 |
American Cyanamid Company |
Dihydro derivatives of LL-E33288 antibiotics
|
US4837206A
(en)
|
1987-04-29 |
1989-06-06 |
Bristol-Myers Company |
Esperamicin derivatives
|
LU87693A1
(fr)
|
1990-03-07 |
1991-10-08 |
Wurth Paul Sa |
Sonde de prise d'echantillons gazeux et de mesures thermiques dans un four a cuve
|
US5264586A
(en)
|
1991-07-17 |
1993-11-23 |
The Scripps Research Institute |
Analogs of calicheamicin gamma1I, method of making and using the same
|
US5589458A
(en)
|
1992-11-13 |
1996-12-31 |
Thomas Jefferson University |
Compounds that inhibit T cell proliferation and methods for using the same
|
US5817303A
(en)
|
1995-05-05 |
1998-10-06 |
Protein Polymer Technologies, Inc. |
Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer
|
US5712127A
(en)
|
1996-04-29 |
1998-01-27 |
Genescape Inc. |
Subtractive amplification
|
US5871917A
(en)
|
1996-05-31 |
1999-02-16 |
North Shore University Hospital Research Corp. |
Identification of differentially methylated and mutated nucleic acids
|
US6617434B1
(en)
|
1996-05-31 |
2003-09-09 |
North Shore Long Island Jewish Research Institute |
Identificiaton of differentially methylated and mutated nucleic acids
|
US7411051B2
(en)
|
1997-03-07 |
2008-08-12 |
Human Genome Sciences, Inc. |
Antibodies to HDPPA04 polypeptide
|
US6057098A
(en)
|
1997-04-04 |
2000-05-02 |
Biosite Diagnostics, Inc. |
Polyvalent display libraries
|
EP0911342B2
(en)
|
1997-04-15 |
2013-05-22 |
Daiichi Sankyo Company, Limited |
Novel protein and process for producing the same
|
FR2767337B1
(fr)
|
1997-08-14 |
2002-07-05 |
Pasteur Institut |
Sequences nucleiques de polypeptides exportes de mycobacteri es, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose
|
JP2002505108A
(ja)
|
1998-03-04 |
2002-02-19 |
ジェネンコア インターナショナル インコーポレーテッド |
プルラナーゼの修飾形態
|
US6472367B1
(en)
|
1998-05-05 |
2002-10-29 |
Adherex Technologies, Inc. |
Compounds and methods for modulating OB-cadherin mediated cell adhesion
|
US7060433B1
(en)
|
1999-11-12 |
2006-06-13 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for screening using diphtheria toxin constructs
|
US7090976B2
(en)
|
1999-11-10 |
2006-08-15 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions comprising Renilla GFP
|
US7534579B2
(en)
|
1998-06-30 |
2009-05-19 |
Millennium Pharmaceuticals, Inc. |
14273 receptor, a novel G-protein coupled receptor
|
US7662409B2
(en)
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
US7488590B2
(en)
|
1998-10-23 |
2009-02-10 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
US20030104526A1
(en)
|
1999-03-24 |
2003-06-05 |
Qiang Liu |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
US6943235B1
(en)
|
1999-04-12 |
2005-09-13 |
Agensys, Inc. |
Transmembrane protein expressed in prostate cancer
|
US6942981B1
(en)
|
1999-05-14 |
2005-09-13 |
Arbor Vita Corporation |
Method of determining interactions with PDZ-domain polypeptides
|
US20090175821A1
(en)
|
1999-05-17 |
2009-07-09 |
Bridon Dominique P |
Modified therapeutic peptides with extended half-lives in vivo
|
AU6226100A
(en)
|
1999-07-19 |
2001-04-24 |
Epimmune, Inc. |
Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
|
DK1967586T3
(da)
|
2000-01-26 |
2011-06-20 |
Agensys Inc |
84P2A9: prostata- og testikelspecifikt protein med høj ekspression ved prostatacancer
|
US7585839B2
(en)
|
2000-02-23 |
2009-09-08 |
Zealand Pharma A/S |
Medical uses of intercellular communication facilitating compounds
|
US7378248B2
(en)
|
2000-03-06 |
2008-05-27 |
Rigel Pharmaceuticals, Inc. |
In vivo production of cyclic peptides for inhibiting protein-protein interaction
|
EP1300418A1
(en)
|
2001-10-04 |
2003-04-09 |
Erasmus Universiteit Rotterdam |
Gene regulation by oligopeptides
|
US7358330B2
(en)
|
2001-03-29 |
2008-04-15 |
Biotempt B.V. |
Immunoregulatory compositions
|
TWI318983B
(en)
|
2000-05-02 |
2010-01-01 |
Uab Research Foundation |
An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
|
US6635448B2
(en)
|
2000-08-21 |
2003-10-21 |
Clonexdevelopment, Inc. |
Methods and compositions for increasing protein yield from a cell culture
|
US7358353B2
(en)
|
2000-08-22 |
2008-04-15 |
Agensys, Inc. |
Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
|
EP1315965A4
(en)
|
2000-09-08 |
2006-04-05 |
Univ Texas |
METHODS AND COMPOSITIONS FOR IN VITRO TARGETING
|
US7608704B2
(en)
|
2000-11-08 |
2009-10-27 |
Incyte Corporation |
Secreted proteins
|
US20040082508A1
(en)
|
2000-11-08 |
2004-04-29 |
Henry Yue |
Secreted proteins
|
AU2002222747A1
(en)
|
2000-12-12 |
2002-06-24 |
Angiolab, Inc. |
Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
|
US7459539B2
(en)
|
2000-12-15 |
2008-12-02 |
Agensys, Inc. |
Antibody that binds zinc transporter protein 108P5H8
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
WO2002064771A1
(fr)
|
2001-02-15 |
2002-08-22 |
Mochida Pharmaceutical Co., Ltd. |
Nouvelle molecule d'adhesion cellulaire specifique de leucocyte active
|
KR100891157B1
(ko)
|
2001-03-28 |
2009-04-07 |
헬릭스 바이오메딕스, 인코포레이티드 |
짧은 생물활성 펩티드 및 그것들의 사용 방법
|
EP1573024A4
(en)
|
2001-04-10 |
2007-08-29 |
Agensys Inc |
NUCLEIC ACIDS AND SUITABLE PROTEINS SUITABLE FOR THE TREATMENT AND EVIDENCE OF VARIOUS CANCER DISEASES
|
US6967021B2
(en)
|
2001-04-27 |
2005-11-22 |
Trustees Of Tufts College |
Use of Galectin-3 to promote the re-epithelialization of wounds
|
WO2002090533A2
(en)
|
2001-05-07 |
2002-11-14 |
National Research Council Of Canada |
Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
|
JP2004529740A
(ja)
|
2001-06-15 |
2004-09-30 |
ジョーンズ ホプキンズ シンガポール ピーティーイー リミテッド |
生体機能繊維
|
DK2295081T3
(en)
|
2001-06-26 |
2019-02-18 |
Amgen Inc |
Antibodies to OPGL
|
US7033991B2
(en)
|
2001-07-16 |
2006-04-25 |
Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College |
Inhibiting furin with polybasic peptides
|
US7858560B2
(en)
|
2001-07-16 |
2010-12-28 |
Caprotec Bioanalytics Gmbh |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
US20090075377A1
(en)
|
2001-08-03 |
2009-03-19 |
Arbor Vita Corporation |
Molecular interactions in cells
|
US7402664B2
(en)
|
2002-09-03 |
2008-07-22 |
Genencor International, Inc. |
Nucleic acids and expression vectors comprising carotenoid binding peptides
|
JP4120778B2
(ja)
|
2001-09-26 |
2008-07-16 |
国立大学法人 奈良先端科学技術大学院大学 |
骨代謝異常疾患マーカー及びその利用
|
EP1456655A2
(en)
|
2001-11-13 |
2004-09-15 |
Incyte Genomics, Inc. |
Receptors and membrane-associated proteins
|
JP2003210166A
(ja)
|
2001-11-16 |
2003-07-29 |
Sanyo Chem Ind Ltd |
変温動物由来細胞の細胞接着基材
|
US20080242837A1
(en)
|
2001-12-21 |
2008-10-02 |
Khan Nisar A |
Peptide compositions
|
US7501391B2
(en)
|
2001-12-21 |
2009-03-10 |
Biotempt B.V. |
Treatment of transplant survival
|
US7786084B2
(en)
|
2001-12-21 |
2010-08-31 |
Biotempt B.V. |
Treatment of burns
|
US20080242618A1
(en)
|
2001-12-21 |
2008-10-02 |
Khan Nisar A |
Stratification
|
US20080318871A1
(en)
|
2001-12-21 |
2008-12-25 |
Khan Nisar A |
Treatment of neurological disorders
|
US7560433B2
(en)
|
2001-12-21 |
2009-07-14 |
Biotempt B.V. |
Treatment of multiple sclerosis (MS)
|
US20080194489A1
(en)
|
2001-12-21 |
2008-08-14 |
Khan Nisar A |
Treatment of iatrogenic disease
|
US7635681B2
(en)
|
2002-01-09 |
2009-12-22 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
US7514407B2
(en)
|
2002-03-04 |
2009-04-07 |
Nymox Corporation |
Spheron component peptides and pharmaceutical compositions
|
US8298606B2
(en)
|
2002-03-08 |
2012-10-30 |
The Regents Of The University Of California |
Methods and compositions for stabilizing the myocardium
|
AU2003210054A1
(en)
|
2002-03-21 |
2003-10-08 |
Komed Co., Ltd. |
Anti-rank monoclonal antibodies and pharmaceutical composition containing the same
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
AU2003243139B2
(en)
|
2002-04-05 |
2007-06-21 |
Amgen Inc. |
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
|
US20040102608A1
(en)
|
2002-05-13 |
2004-05-27 |
Cornell Research Foundation, Inc. |
Multiblock copolymers having improved mechanical properties
|
AU2003239531A1
(en)
|
2002-05-17 |
2003-12-02 |
Montana State University |
Protein cages for the delivery of medical imaging and therapy
|
BRPI0311822B8
(pt)
|
2002-06-06 |
2021-05-25 |
Oncotherapy Science Inc |
composição farmacêutica para o tratamento de câncer
|
CA2491053A1
(en)
|
2002-06-28 |
2004-01-08 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Use of antibodies against flt-1 for the treatment of osteoporosis
|
EP1911765A3
(en)
|
2002-07-24 |
2008-04-23 |
Innogenetics N.V. |
Prevention, treatment and diagnosis of diseases associated with Beta-Amyloid formation and/or aggregation
|
AU2003275473A1
(en)
|
2002-10-08 |
2004-05-04 |
Genencor International, Inc. |
Phenolic binding peptides
|
US7572894B2
(en)
|
2002-11-01 |
2009-08-11 |
Trustees Of Tufts College |
Templated native silk smectic gels
|
JP4485367B2
(ja)
|
2002-12-03 |
2010-06-23 |
パソゲン リムーバル アンド ダイアグノスティック テクノロジーズ インコーポレイテッド |
プリオンタンパク質リガンドおよび使用方法
|
JP2004189848A
(ja)
|
2002-12-10 |
2004-07-08 |
Giken:Kk |
炭化処理方法および炭化処理システム
|
EP2259068B1
(en)
|
2003-01-16 |
2013-08-14 |
caprotec bioanalytics GmbH |
Capture compounds and methods for analyzing the proteome
|
JP3906924B2
(ja)
|
2003-02-28 |
2007-04-18 |
独立行政法人農業生物資源研究所 |
絹タンパクから細胞生育ペプチドの抽出と利用
|
US7547512B2
(en)
|
2003-03-24 |
2009-06-16 |
The University Of Hong Kong |
High-throughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS)
|
US7375202B2
(en)
|
2003-03-24 |
2008-05-20 |
The University Of Hong Kong |
Human virus causing severe acute respiratory syndrome (SARS) and uses thereof
|
US7517529B2
(en)
|
2003-04-08 |
2009-04-14 |
Biotempt B.V. |
Treatment of type I diabetes
|
CA2562415C
(en)
|
2003-04-10 |
2015-10-27 |
Tufts University |
Concentrated aqueous silk fibroin solutions free of organic solvents and uses thereof
|
US20090005257A1
(en)
|
2003-05-14 |
2009-01-01 |
Jespers Laurent S |
Process for Recovering Polypeptides that Unfold Reversibly from a Polypeptide Repertoire
|
JP3915983B2
(ja)
|
2003-05-27 |
2007-05-16 |
ゼライス株式会社 |
プロテアーゼ、このプロテアーゼをコードするdna、プロテアーゼの製造方法
|
EP1633380A4
(en)
|
2003-06-19 |
2010-08-11 |
Yeda Res & Dev |
ANTIMICROBIAL AND ANTICANCER LIPOPEPTIDES
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
FR2860237B1
(fr)
|
2003-09-30 |
2006-03-10 |
Centre Nat Rech Scient |
Polypeptide d'interaction comprenant un motif heptapeptidique et un domaine de penetration cellulaire
|
US20050118625A1
(en)
|
2003-10-02 |
2005-06-02 |
Mounts William M. |
Nucleic acid arrays for detecting gene expression associated with human osteoarthritis and human proteases
|
US20090226374A1
(en)
|
2003-10-27 |
2009-09-10 |
Health Aide, Inc. |
Anaphylatoxins for detecting clinical conditions
|
US20050153333A1
(en)
|
2003-12-02 |
2005-07-14 |
Sooknanan Roy R. |
Selective terminal tagging of nucleic acids
|
AT412785B
(de)
|
2003-12-04 |
2005-07-25 |
Kungl Andreas J Dr |
Gag-bindungsproteine
|
EP1544215A1
(en)
|
2003-12-17 |
2005-06-22 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Human anti-idiotypic antibody fragments that mimic HER-2/neu
|
US20090227505A1
(en)
|
2004-01-07 |
2009-09-10 |
Biotempt B.V. |
Methods and uses for protein breakdown products
|
WO2005066337A2
(en)
|
2004-01-09 |
2005-07-21 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation
|
WO2005072392A2
(en)
|
2004-01-28 |
2005-08-11 |
John Hopkins University |
Methods for making and using molecular switches involving circular permutation
|
TWI359026B
(en)
|
2004-02-12 |
2012-03-01 |
Sankyo Co |
Pharmaceutical composition for the osteoclast rela
|
ATE452147T1
(de)
|
2004-02-19 |
2010-01-15 |
Genentech Inc |
Antikörper mit korrigierten cdr
|
JP2008509073A
(ja)
|
2004-03-01 |
2008-03-27 |
ペプテラ ファーマスーティカルズ エルティーディー. |
カゼイン由来ペプチドおよびその治療的使用
|
TW200539855A
(en)
|
2004-03-15 |
2005-12-16 |
Wyeth Corp |
Calicheamicin conjugates
|
WO2005098043A2
(en)
|
2004-03-30 |
2005-10-20 |
The President And Fellows Of Harvard College |
Ligand-dependent protein splicing
|
WO2005100392A2
(en)
|
2004-04-08 |
2005-10-27 |
Sangamo Biosciences, Inc. |
Treatment of neuropathic pain with zinc finger proteins
|
US7189697B2
(en)
|
2004-04-13 |
2007-03-13 |
Trustees Of Tufts College |
Compositions and uses of a galectin for treatment of dry eye syndrome
|
US7603239B2
(en)
|
2004-05-05 |
2009-10-13 |
Massachusetts Institute Of Technology |
Methods and systems for generating peptides
|
JP2008505928A
(ja)
|
2004-07-08 |
2008-02-28 |
アムジェン インコーポレーテッド |
治療用ペプチド
|
WO2006017173A1
(en)
|
2004-07-10 |
2006-02-16 |
Alexion Pharmaceuticals, Inc. |
Methods for discovering antibodies specific to cancer cells and antibodies discovered thereby
|
AT413946B
(de)
|
2004-07-13 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff gegen die alzheimer-krankheit
|
JP2008508320A
(ja)
|
2004-07-29 |
2008-03-21 |
カイロン コーポレイション |
Streptococcusagalactiaeのようなグラム陽性細菌に対する免疫原性組成物
|
AU2005267734A1
(en)
|
2004-08-06 |
2006-02-09 |
Sopherion Therapeutics, Inc. |
Anti-angiogenic peptides and methods of use thereof
|
JP2006068378A
(ja)
|
2004-09-03 |
2006-03-16 |
Terumo Corp |
血管内留置物
|
US7265092B2
(en)
|
2004-09-30 |
2007-09-04 |
Kai Pharmaceuticals, Inc. |
Pharmaceutical formulation
|
MX2007004188A
(es)
|
2004-10-13 |
2007-10-11 |
Crucell Holland Bv |
Vectores adenovirales mejorados y usos de los mismos.
|
EP1812030A4
(en)
|
2004-10-14 |
2009-01-14 |
Sopherion Therapeutics Inc |
ANTI-ANGIOGENIC PEPTIDES AND METHODS OF USE THEREOF
|
US20080176790A1
(en)
|
2004-10-29 |
2008-07-24 |
Defrees Shawn |
Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf)
|
CA2629751A1
(en)
|
2004-11-12 |
2006-05-18 |
The University Of British Columbia |
Antimicrobial peptides
|
WO2007046818A2
(en)
|
2004-11-16 |
2007-04-26 |
Board Of Regents, The University Of Texas System |
Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display
|
WO2006062776A2
(en)
|
2004-11-29 |
2006-06-15 |
The Regents Of The University Of California |
Hydroxyapatite-binding peptides for bone growth and inhibition
|
US7947436B2
(en)
|
2004-12-13 |
2011-05-24 |
Alethia Biotherapeutics Inc. |
Polynucleotides and polypeptide sequences involved in the process of bone remodeling
|
WO2006078746A2
(en)
|
2005-01-19 |
2006-07-27 |
Mathew Mark Zuckerman |
Method, compositions and classification for tumor diagnostics and treatment
|
JP2008528668A
(ja)
|
2005-02-03 |
2008-07-31 |
アンチトープ リミテッド |
ヒト抗体及びタンパク質
|
CA2597191C
(en)
|
2005-02-09 |
2014-04-01 |
Helix Biomedix Inc. |
Antimicrobial hexapeptides
|
US8551774B2
(en)
|
2005-03-17 |
2013-10-08 |
National Research Council Of Canada |
Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the Gly-Gly-Ala domain for enhanced transient gene expression
|
US9162005B2
(en)
|
2005-04-25 |
2015-10-20 |
Arch Biosurgery, Inc. |
Compositions for prevention of adhesions and other barrier applications
|
JP2008539209A
(ja)
|
2005-04-26 |
2008-11-13 |
カリヨン−シーティーティー リミテッド |
診断及び治療剤
|
CA2609038A1
(en)
|
2005-05-18 |
2006-11-23 |
Trinity Biosystems, Inc. |
Methods and compositions for immunizing against chlamydia infection
|
US7528232B2
(en)
|
2005-05-20 |
2009-05-05 |
The University Of Kentucky Research Foundation |
Utility of phylloplanins as antibiotics, selective fungicides and for enhancing microbial resistance in crop plants
|
US8227573B2
(en)
|
2005-05-20 |
2012-07-24 |
University Of Kentucky Research Foundation |
Utility of phylloplanins as antibiotics, selective fungicides and for enhancing microbial resistance in plants
|
CN101217971B
(zh)
|
2005-07-05 |
2011-11-09 |
比奥滕普特公司 |
肿瘤的治疗
|
JP4604184B2
(ja)
|
2005-07-12 |
2010-12-22 |
独立行政法人産業技術総合研究所 |
新規糖鎖認識蛋白質及びその遺伝子
|
JP2009504156A
(ja)
|
2005-08-11 |
2009-02-05 |
ザ スクリップス リサーチ インスティテュート |
Cnnに対するジンクフィンガー結合ドメイン
|
JP2009528255A
(ja)
|
2005-08-22 |
2009-08-06 |
ジェネンコー・インターナショナル・インク |
反復配列タンパク質とフィロケイ酸塩粘土とのナノコンポジットおよびその調製
|
WO2007027954A2
(en)
|
2005-08-30 |
2007-03-08 |
Children's Hospital & Research Center At Oakland |
Methods for identifying an epitope of a polypeptide, chlamydial antigenic polypeptides identified thereby, and methods of use thereof
|
US20090275503A1
(en)
|
2005-09-22 |
2009-11-05 |
Yeda Research And Developent Co., Ltd. At The Weizman Institute Of Science |
Diastereomeric peptides for modulating t cell immunity
|
AU2006294663B2
(en)
|
2005-09-26 |
2012-03-22 |
Medarex, Inc. |
Human monoclonal antibodies to CD70
|
US7846445B2
(en)
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
US20090099031A1
(en)
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
CA2624081C
(en)
|
2005-09-29 |
2014-09-16 |
Medimmune, Inc. |
Method of identifying membrane ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells
|
PT1934252E
(pt)
|
2005-10-13 |
2015-10-12 |
Biocon Ltd |
Processo para a preparação de conjugados de insulina
|
US7575876B2
(en)
|
2005-10-27 |
2009-08-18 |
The University Of Washington |
Biomarkers for neurodegenerative disorders
|
CN101310177B
(zh)
|
2005-11-08 |
2011-12-21 |
国立大学法人东北大学 |
用质谱仪定量膜蛋白质的方法
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
WO2007145659A1
(en)
|
2005-11-10 |
2007-12-21 |
The Regents Of The University Of California |
Synthetic ldl as targeted drug delivery vehicle
|
EP1963499A4
(en)
|
2005-11-28 |
2009-04-08 |
Scripps Research Inst |
ZINCFINGER BINDING DOMAIN FOR TNN
|
GB0524313D0
(en)
|
2005-11-29 |
2006-01-04 |
Imp College Innovations Ltd |
Particles
|
WO2007069817A1
(en)
|
2005-12-16 |
2007-06-21 |
National Cancer Center |
Peptides for inhibiting transglutaminase
|
US7989160B2
(en)
|
2006-02-13 |
2011-08-02 |
Alethia Biotherapeutics Inc. |
Polynucleotides and polypeptide sequences involved in the process of bone remodeling
|
US8168181B2
(en)
|
2006-02-13 |
2012-05-01 |
Alethia Biotherapeutics, Inc. |
Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
|
DK1986611T3
(da)
|
2006-02-23 |
2013-07-29 |
Danisco Us Inc |
Proteinpolymernanopartikler med repeat-sekvens, der eventuelt indeholder aktive stoffer, og fremstilling heraf
|
US8183432B2
(en)
|
2006-02-28 |
2012-05-22 |
Japan Science And Technology Agency |
Plant having reduced lignin and cellulose contents without reducing glucan content, method of producing the same and utilization thereof
|
US7501557B1
(en)
|
2006-02-28 |
2009-03-10 |
University Of Kentucky Research Foundation |
Method utilizing the tobacco phylloplanin promoter for expression of nucleic acids as gene products directed to aerial surfaces of plants
|
WO2007104062A2
(en)
|
2006-03-09 |
2007-09-13 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods based on peptide binding profiling
|
WO2007108205A1
(ja)
|
2006-03-17 |
2007-09-27 |
Sanyo Chemical Industries, Ltd. |
細胞培養用担体
|
WO2007111952A2
(en)
|
2006-03-22 |
2007-10-04 |
The Scripps Research Institute |
Method of preparing glycopeptides
|
AU2007245164A1
(en)
|
2006-03-28 |
2007-11-08 |
Biogen Idec Ma Inc. |
Anti-IGF-IR antibodies and uses thereof
|
US9283260B2
(en)
|
2006-04-21 |
2016-03-15 |
Amgen Inc. |
Lyophilized therapeutic peptibody formulations
|
EP2021467A4
(en)
|
2006-05-08 |
2010-01-20 |
Adaerata Ltd Partnership |
CHIMERIC PCSK9 PROTEINS, THESE INCLUDING CELLS AND TEST METHODS THEREWITH
|
FR2900826B1
(fr)
|
2006-05-12 |
2008-08-15 |
Soc Extraction Principes Actif |
Utilisation de peptides en tant que principes actifs amincissants.
|
US20080069801A1
(en)
|
2006-06-13 |
2008-03-20 |
Lee Randall J |
Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications
|
WO2008006028A2
(en)
|
2006-07-05 |
2008-01-10 |
The Scripps Research Institute |
Chimeric zinc finger recombinases optimized for catalysis by directed evolution
|
EP2041569A4
(en)
|
2006-07-08 |
2009-11-18 |
Univ Kentucky Res Found |
DIAGNOSTIC TEST OF LUNG CANCER
|
CA2660286A1
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
CL2007002502A1
(es)
|
2006-08-31 |
2008-05-30 |
Hoffmann La Roche |
Variantes del factor de crecimiento similar a insulina-1 humano (igf-1) pegilados en lisina; metodo de produccion; proteina de fusion que la comprende; y su uso para tratar la enfermedad de alzheimer.
|
JP2008094822A
(ja)
|
2006-09-15 |
2008-04-24 |
Univ Of Tokyo |
セルロース結合性ペプチドおよびその製造方法
|
EP2097536B1
(en)
|
2006-10-31 |
2014-07-16 |
MUSC Foundation For Research Development |
Systems for in vivo measurement of interstitial biological activity, processes and/or compositions
|
CN101636175A
(zh)
|
2006-11-01 |
2010-01-27 |
乔治梅森知识产权公司 |
用于神经病况的生物标记
|
ITTO20060852A1
(it)
|
2006-11-30 |
2008-06-01 |
Univ Degli Studi Torino |
Peptidi metastasi-specifici e loro applicazioni diagnostiche e terapeutiche
|
CA2989778C
(en)
|
2007-01-19 |
2020-06-30 |
Kai Pharmaceuticals, Inc. |
Method of modifying peptide compositions
|
US9175422B2
(en)
|
2007-01-22 |
2015-11-03 |
The United States Of America As Represented By The Secretary Of The Army |
Polymer-micelle complex as an aid to electrospinning
|
EP2129682A4
(en)
|
2007-01-29 |
2011-07-20 |
Procell Therapeutics Inc |
NOVEL DOMAINS OF MACROMOLECULE TRANSDUCTION AND METHODS OF IDENTIFICATION AND USES THEREOF
|
CL2008000493A1
(es)
|
2007-02-16 |
2008-06-27 |
Genentech Inc |
Polipeptido que se une especificamente a un dominio pdz de la proteina htra1; polinucleotido que lo codifica; metodo de produccion; anticuerpo que se une a el; y su uso para tratar patologias relacionadas con la proteina htra1.
|
CA2680824C
(en)
|
2007-03-14 |
2018-06-26 |
Arch Therapeutics, Inc. |
Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
|
WO2008112904A2
(en)
|
2007-03-15 |
2008-09-18 |
Invitrogen Corporation |
Adhering surfaces
|
US8318135B2
(en)
|
2007-03-19 |
2012-11-27 |
National Research Council Of Canada |
Antagonist of ligands and uses thereof
|
EP2155782A2
(en)
|
2007-03-26 |
2010-02-24 |
Dako Denmark A/S |
Mhc peptide complexes and uses thereof in infectious diseases
|
JP2008263955A
(ja)
|
2007-03-29 |
2008-11-06 |
Sanyo Chem Ind Ltd |
無血清培地
|
US20080306001A1
(en)
|
2007-04-04 |
2008-12-11 |
Anzelika Liik |
Transcriptional modulation of extracellular matrix (ecm) of dermal fibroblasts
|
WO2008137122A2
(en)
|
2007-05-04 |
2008-11-13 |
Shiloh Laoratories, Inc. |
Inducing premature senescence to stabilize stem cell feeder layer cells
|
US8097581B2
(en)
|
2007-05-10 |
2012-01-17 |
Grant Industries Inc. |
Anti-wrinkle cosmetic composition
|
US20100093554A1
(en)
|
2007-06-01 |
2010-04-15 |
Keting Chu |
Methods for identifying biomarkers, autoantibody signatures, and stratifying subject groups using peptide arrays
|
EP2009023A1
(en)
|
2007-06-04 |
2008-12-31 |
Rentschler Beteiligungs GmbH |
Novel peptides and their use for the treatment of edema
|
AU2008266060B2
(en)
|
2007-06-13 |
2013-08-29 |
Fmc Corporation |
Alginate coated, polysaccharide gel-containing foam composite, preparative methods, and uses thereof
|
WO2008157299A2
(en)
|
2007-06-15 |
2008-12-24 |
Wyeth |
Differential expression profiling analysis of cell culture phenotypes and uses thereof
|
US20100016215A1
(en)
|
2007-06-29 |
2010-01-21 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
AU2008271050B2
(en)
|
2007-06-29 |
2014-11-06 |
Sarepta Therapeutics, Inc. |
Tissue specific peptide conjugates and methods
|
AU2008273096B2
(en)
|
2007-07-12 |
2013-05-02 |
Academisch Ziekenhuis Leiden |
Molecules for targeting compounds to various selected organs or tissues
|
CL2008002085A1
(es)
|
2007-07-16 |
2008-11-21 |
Genentech Inc |
Anticuerpo humanizado anti-cd79b/igbeta/b29; polinucleotido codificacnte, vector, celula huesped; metodo de fabricacion; inmunoconjugado; composicion farmaceutica; uso para tratar cancer; metodo in vitro para determinar presencia de cd79b, oinhibir crecimiento de celulas quqe expresa cd79b; ensayo in vitro para detectar celulas b
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
US8314291B2
(en)
|
2007-08-06 |
2012-11-20 |
University Of Tsukuba |
Method for producing plant with modified flower morphology
|
WO2009023125A1
(en)
|
2007-08-14 |
2009-02-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Neuronostatin and its uses
|
EP2185701A4
(en)
|
2007-08-15 |
2011-03-02 |
Amunix Operating Inc |
COMPOSITIONS AND METHODS FOR ENHANCING THE PRODUCTION OF RECOMBINANT POLYPEPTIDES
|
US8809521B2
(en)
|
2007-08-28 |
2014-08-19 |
Fmc Biopolymer As |
Delayed self-gelling alginate systems and uses thereof
|
EP2185707B1
(en)
|
2007-09-04 |
2013-07-03 |
Procell Therapeutics Inc. |
Cell permeable nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same
|
KR100887266B1
(ko)
|
2007-09-04 |
2009-03-06 |
주식회사 프로셀제약 |
세포투과성 p18 재조합 단백질, 이를 코딩하는폴리뉴클레오티드 및 이를 유효성분으로 함유하는 항암조성물
|
JP5000439B2
(ja)
|
2007-09-19 |
2012-08-15 |
三洋化成工業株式会社 |
細胞培養用担体
|
KR20100075483A
(ko)
|
2007-09-20 |
2010-07-02 |
더 제이. 데이비드 글래드스톤 인스티튜트 |
장산재 핵 요소 폴리펩티드 조성물 및 그것의 사용방법
|
EP2197908A2
(en)
|
2007-09-27 |
2010-06-23 |
Dako Denmark A/S |
Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
|
SI2206727T1
(sl)
|
2007-10-11 |
2015-06-30 |
Daiichi Sankyo Company, Limited |
Protitelo, ki cilja osteoklast - soroden protein Siglec-15
|
GB0720156D0
(en)
|
2007-10-15 |
2007-11-28 |
Univ Nottingham Trent |
Breast cancer associated antigen
|
CA2701420C
(en)
|
2007-10-29 |
2016-02-09 |
Helix Biomedix Inc. |
Protective skin care tetrapeptides
|
US7923253B2
(en)
|
2007-11-05 |
2011-04-12 |
Battelle Memorial Institute |
Method for identifying type I diabetes mellitus in humans
|
JP6039879B2
(ja)
|
2007-11-05 |
2016-12-07 |
ノルディック・ビオサイエンス・エー/エスNordic Bioscience A/S |
Cvdリスク評価のための生化学マーカー
|
WO2009061130A2
(en)
|
2007-11-06 |
2009-05-14 |
Procell Therapeutics Inc. |
Cell permeable runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same
|
WO2009059379A1
(en)
|
2007-11-07 |
2009-05-14 |
Dynamic Microbials Limited |
Antimicrobial compositions, formulations and uses thereof
|
US20100240057A1
(en)
|
2007-11-08 |
2010-09-23 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of chronic myeloid leukemia and acute lymphoblastic leukemia
|
JP4932940B2
(ja)
|
2007-11-12 |
2012-05-16 |
セラクローン サイエンシーズ, インコーポレイテッド |
インフルエンザの治療および診断のための組成物および方法
|
FR2925500B1
(fr)
|
2007-12-21 |
2011-05-06 |
Vincience |
Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
|
FR2925501B1
(fr)
|
2007-12-21 |
2012-12-14 |
Vincience |
Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
|
WO2009090651A2
(en)
|
2008-01-15 |
2009-07-23 |
Technion Research And Development Foundation Ltd. |
Major histocompatibility complex hla-b2705 ligands useful for therapy and diagnosis
|
CA2713089C
(en)
|
2008-01-23 |
2017-11-21 |
Dana Farber Cancer Institute |
Compositions and methods for the treatment of viral infections
|
EP2250278B1
(en)
|
2008-02-21 |
2023-04-05 |
Burnham Institute for Medical Research |
Methods and compositions related to peptides and proteins with c-terminal elements
|
US20090298707A1
(en)
|
2008-03-18 |
2009-12-03 |
The Regents Of The University Of California |
Sparse matrix system and method for identification of specific ligands or targets
|
WO2009146179A1
(en)
|
2008-04-15 |
2009-12-03 |
University Of Iowa Research Foundation |
Zinc finger nuclease for the cftr gene and methods of use thereof
|
EP2113255A1
(en)
|
2008-05-02 |
2009-11-04 |
f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. |
Cytotoxic immunoglobulin
|
US20090281038A1
(en)
|
2008-05-09 |
2009-11-12 |
University Of Kentucky Research Foundation |
Phylloplanins Inhibition of Microbial Growth on Organic Materials
|
WO2009139599A2
(ko)
|
2008-05-16 |
2009-11-19 |
주식회사 프로셀제약 |
세포투과성 p27 재조합 단백질, 이를 코딩하는 폴리뉴클레오티드 및 이를 유효성분으로 함유하는 항암 조성물
|
CA2728926A1
(en)
|
2008-07-04 |
2010-01-07 |
Basf Plant Science Gmbh |
Plants having enhanced yield-related traits and a method for making the same by overexpressing a polynucleotide encoding a tfl1-like protein
|
TR201821216T4
(tr)
|
2008-09-17 |
2019-01-21 |
Xencor Inc |
Ige-aracılı rahatsızlıkların tedavisine yönelik kompozisyonlar ve yöntemler.
|
JP5299956B2
(ja)
|
2008-09-29 |
2013-09-25 |
国立大学法人東北大学 |
質量分析装置を用いた代謝酵素群の一斉タンパク質定量に用いるペプチド
|
EP2337795A2
(en)
|
2008-10-01 |
2011-06-29 |
Dako Denmark A/S |
Mhc multimers in cancer vaccines and immune monitoring
|
AU2010221186B2
(en)
|
2009-03-05 |
2013-08-22 |
E. R. Squibb & Sons, L.L.C. |
Fully human antibodies specific to CADM1
|
CN106317224B
(zh)
|
2009-04-09 |
2020-05-12 |
第一三共株式会社 |
抗-Siglec-15抗体
|
BR112012025730B1
(pt)
|
2010-04-09 |
2020-12-08 |
Aveo Pharmaceuticals, Inc |
anticorpo isolado que se liga ao erbb3 humano, seus usos, seu processo de produção e vetor de expressão
|
CN103237813A
(zh)
|
2010-10-05 |
2013-08-07 |
第一三共株式会社 |
靶向破骨细胞相关蛋白涎免凝集素-15的抗体
|
SG11201405966PA
(en)
|
2012-03-30 |
2014-11-27 |
Daiichi Sankyo Co Ltd |
Cdr-modified anti-siglec-15 antibody
|
ES2723885T3
(es)
|
2012-07-19 |
2019-09-03 |
Daiichi Sankyo Co Ltd |
Anticuerpos anti-Siglec-15
|